Pictet Asset Management Ltd. increased its holdings in shares of Humana Inc. (NYSE:HUM) by 6.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 178,098 shares of the insurance provider’s stock after acquiring an additional 10,276 shares during the quarter. Pictet Asset Management Ltd. owned approximately 0.12% of Humana worth $43,390,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in Humana by 1.6% during the second quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock worth $2,380,366,000 after acquiring an additional 157,868 shares during the period. FMR LLC lifted its holdings in Humana by 29.3% during the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after acquiring an additional 1,479,210 shares during the period. Capital Research Global Investors lifted its holdings in Humana by 9.7% during the second quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock worth $940,182,000 after acquiring an additional 346,069 shares during the period. Renaissance Technologies LLC lifted its holdings in Humana by 1.5% during the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock worth $657,157,000 after acquiring an additional 39,400 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Humana by 2.7% during the second quarter. Bank of New York Mellon Corp now owns 2,016,141 shares of the insurance provider’s stock worth $485,124,000 after acquiring an additional 53,664 shares during the period. Institutional investors and hedge funds own 95.79% of the company’s stock.
In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the firm’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now directly owns 18,042 shares of the company’s stock, valued at $4,672,878. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total value of $770,759.58. Following the sale, the insider now directly owns 7,681 shares in the company, valued at $1,927,777.38. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,595 shares of company stock worth $14,133,706. 0.80% of the stock is owned by insiders.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period last year, the firm earned $2.30 EPS.
The business also recently announced a dividend, which was paid on Monday, October 16th. Investors of record on Friday, September 29th were issued a $0.40 dividend. The ex-dividend date of this dividend was Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.
TRADEMARK VIOLATION WARNING: “Humana Inc. (HUM) Position Increased by Pictet Asset Management Ltd.” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.com-unik.info/2017/11/02/humana-inc-hum-position-increased-by-pictet-asset-management-ltd.html.
A number of brokerages recently commented on HUM. Credit Suisse Group reiterated an “outperform” rating and set a $260.00 price target (up from $250.00) on shares of Humana in a report on Thursday, August 3rd. Deutsche Bank AG lifted their price target on Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Oppenheimer Holdings, Inc. lifted their price target on Humana from $236.00 to $255.00 and gave the stock an “outperform” rating in a report on Thursday, August 3rd. BidaskClub lowered Humana from a “hold” rating to a “sell” rating in a report on Thursday, August 17th. Finally, ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Twelve equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Humana has an average rating of “Buy” and an average price target of $253.90.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.